Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 9 results

Ranking

Release Date Sort Sort Article Type

Mass-like lesions as a rare form of neuro-Behçet’s disease: A case report and review of the literature

Nazife Şule Yasar Bilge, Suzan Şaylısoy, Timuçin Kasifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 34-38) DOI: 10.5152/eurjrheum.2014.007

Abstract Full Text (PDF) Related Articles

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Döndü Üsküdar Cansu, Sabri Güncan, N. Şule Yaşar Bilge, Timuçin Kaşifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 62-66) DOI: 10.5152/eurjrheumatol.2014.019

Abstract Full Text (PDF) Related Articles

Is there any relationship between season/weather and oral ulcer in Behçet’s disease?

Döndü Üsküdar Cansu, Timuçin Kaşifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 89-91) DOI: 10.5152/eurjrheumatol.2014.031

Abstract Full Text (PDF) Related Articles

Mass-like lesions as a rare form of neuro-Behçet’s disease: A case report and review of the literature

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Is there any relationship between season/weather and oral ulcer in Behçet’s disease?

The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever

Do clinical findings of Behçet’s disease vary by gender?: A single-center experience from 329 patients

A rare cause of cytopenia in a patient with systemic lupus erythematosus: Autoimmune myelofibrosis

Pauci-immune lupus nephritis: possibility or co-incidence?

Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients